Circulating Soluble Urokinase Plasminogen Activator Receptor and C-Reactive Protein Concentrations in Adults with High-Functioning Autism. [PDF]
Kurtulmuş A +3 more
europepmc +1 more source
suPAR is the circulating factor in some but not all FSGS [PDF]
Howard, Trachtman, Jochen, Reiser
openaire +2 more sources
Evaluating plasma ferritin and suPAR as treatable traits for critically ill patients with COVID-19 treated with anakinra: an exploratory analysis of the immune modulation domain of the REMAP-CAP randomised clinical trial. [PDF]
Boyle AJ +12 more
europepmc +1 more source
Evaluation of Serum Soluble Urokinase Plasminogen Activator Receptor (suPAR) Levels in Different Metabolic Obesity Phenotypes and Their Association with Inflammatory Cytokines: A Cross-Sectional Study. [PDF]
Acet A, Ozdemir C, Solak H.
europepmc +1 more source
Soluble urokinase plasminogen activator receptor - What are the clinical potentials in psychiatry? [PDF]
Huber FG +4 more
europepmc +1 more source
Biomarkers of systemic disease burden and outcomes after transcatheter tricuspid edge-to-edge repair. [PDF]
Schlegl J +9 more
europepmc +1 more source
Proteomics-Based Soluble Urokinase Plasminogen Activator Receptor Levels Are Associated With Adverse Cardiovascular Outcomes in the General Population: Insights From the UK Biobank. [PDF]
Sakr SM +13 more
europepmc +1 more source
Cord blood procalcitonin and soluble urokinase-type plasminogen activator receptor in predicting histological chorioamnionitis - A pilot study. [PDF]
Jalkanen K +7 more
europepmc +1 more source
Plasma suPAR and domain-specific cognitive performance in virologically suppressed women with HIV. [PDF]
Gonzalez H +10 more
europepmc +1 more source

